Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
DXCM
DXCM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DXCM News
Intuitive Surgical and DexCom: Future Prospects Analysis
3h ago
Fool
Intuitive Surgical and DexCom's Growth Prospects Amid Challenges
3h ago
NASDAQ.COM
Investigation into DexCom Officers' Fiduciary Duties
Feb 26 2026
PRnewswire
DexCom Positioned to Benefit from GLP-1 Drug Boom
Feb 25 2026
Fool
DexCom Benefits from the Rise of GLP-1 Medications
Feb 25 2026
NASDAQ.COM
DexCom to Present Company Update at 47th Annual Raymond James Conference
Feb 25 2026
Newsfilter
U.S. Stocks Close Higher as Software Stocks Recover
Feb 14 2026
NASDAQ.COM
Wall Street Rebounds as Inflation Data Surprises
Feb 13 2026
Benzinga
US Stocks Edge Up, Led by Chipmakers' Gains
Feb 13 2026
NASDAQ.COM
Significant Stock Movements for Moderna and Others
Feb 13 2026
CNBC
Coinbase Reports Q4 Revenue Decline of 5%
Feb 13 2026
Benzinga
Soleus Capital Increases Stake in Celcuity
Feb 13 2026
Fool
DexCom Q4 2025 Earnings Call Insights
Feb 13 2026
seekingalpha
DexCom Q4 2025 Financial Results Beat Expectations
Feb 12 2026
seekingalpha
DexCom Reports Strong Quarterly Earnings Exceeding Expectations
Feb 12 2026
Benzinga
DexCompress Releases 2026 Fiscal Guidance
Feb 12 2026
seekingalpha
Show More News